Matteo Cescon Selected Research

Liver Failure

11/2023	Minimally Invasive Versus Open Liver Resections for Hepatocellular Carcinoma in Patients With Metabolic Syndrome.
11/2023	Novel Benchmark Values for Open Major Anatomic Liver Resection in Non-cirrhotic Patients: A Multicentric Study of 44 International Expert Centers.
1/2023	Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry.
2/2021	The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study.
1/2021	Liver resection for perihilar cholangiocarcinoma: Impact of biliary drainage failure on postoperative outcome. Results of an Italian multicenter study.
11/2020	Stratification of Major Hepatectomies According to Their Outcome: Analysis of 2212 Consecutive Open Resections in Patients Without Cirrhosis.
10/2020	Minimally Invasive Stage 1 to Protect Against the Risk of Liver Failure: Results from the Hepatocellular Carcinoma Series of the Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy Italian Registry.
10/2020	A nomogram based on liver stiffness predicts postoperative complications in patients with hepatocellular carcinoma.
10/2017	Adding Liver Stiffness Measurement to the Routine Evaluation of Hepatocellular Carcinoma Resectability Can Optimize Clinical Outcome.
2/2017	Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matteo Cescon Research Topics

Disease

70	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 09/2003
52	Neoplasms (Cancer) 05/2024 - 04/2003
23	Fibrosis (Cirrhosis) 03/2023 - 09/2003
21	Liver Failure 11/2023 - 06/2006
17	End Stage Liver Disease 04/2024 - 06/2006
16	Neoplasm Metastasis (Metastasis) 03/2024 - 10/2002
12	Infections 04/2024 - 10/2009
10	Thrombosis (Thrombus) 03/2023 - 04/2003
8	Liver Diseases (Liver Disease) 12/2023 - 04/2008
8	Hepatitis C 02/2017 - 07/2006
7	Cholangiocarcinoma 01/2024 - 07/2010
7	Portal Hypertension 01/2023 - 12/2009
5	Hepatitis 04/2024 - 11/2003
5	Klatskin Tumor 11/2023 - 01/2021
4	Inflammation (Inflammations) 05/2024 - 06/2011
4	COVID-19 01/2023 - 01/2020
4	Hemorrhage 01/2023 - 09/2003
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 05/2003
3	Necrosis 04/2024 - 12/2004
3	Acute Kidney Injury (Acute Renal Failure) 02/2024 - 01/2021
3	Cholestasis 11/2023 - 11/2013
3	Ascites 11/2023 - 10/2017
3	Brain Death (Brain Dead) 06/2022 - 01/2020
3	Margins of Excision 12/2021 - 04/2009
3	Hypertrophy 02/2021 - 11/2013
3	Varicose Veins (Varicose Vein) 01/2021 - 02/2011
3	Liver Neoplasms (Liver Cancer) 01/2018 - 10/2016
3	Ischemia 01/2012 - 09/2003
2	Cholangitis 12/2023 - 08/2023
2	Death (Near-Death Experience) 01/2023 - 11/2021
2	Thrombocytopenia (Thrombopenia) 04/2022 - 05/2002
2	Sarcopenia 04/2022 - 10/2020
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2020
2	Pancreatic Neoplasms (Pancreatic Cancer) 08/2019 - 04/2009
2	Sepsis (Septicemia) 10/2018 - 09/2003
2	Adenocarcinoma 04/2017 - 05/2016
2	Budd-Chiari Syndrome (Budd Chiari Syndrome) 02/2017 - 12/2007
2	Chronic Hepatitis (Chronic Active Hepatitis) 07/2015 - 06/2010
2	Heart Failure 07/2015 - 09/2003
1	Alcoholism (Alcohol Abuse) 04/2024
1	Brain Diseases (Brain Disorder) 03/2024
1	Tremor (Tremors) 03/2024
1	Jaundice (Icterus) 12/2023
1	Gallstones (Gallstone) 11/2023
1	Hyperbilirubinemia 11/2023
1	Mirizzi Syndrome 11/2023
1	Hypovolemia 01/2023
1	Patent Foramen Ovale 01/2023
1	Obesity 01/2023
1	Mesothelioma 01/2023

Drug/Important Bio-Agent (IBA)

9	Antiviral Agents (Antivirals)IBA 09/2020 - 11/2003
5	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2007
5	BilirubinIBA 11/2023 - 06/2012
5	Sorafenib (BAY 43-9006)FDA Link 06/2023 - 01/2017
5	dicarboxydine (DCD)IBA 01/2023 - 01/2021
5	alpha-Fetoproteins (alpha-Fetoprotein)IBA 04/2021 - 03/2004
4	6-propylchromone-2-carboxylic acid (PCCA)IBA 11/2023 - 11/2021
3	BismuthIBA 12/2023 - 11/2021
3	MicroRNAs (MicroRNA)IBA 01/2020 - 04/2018
3	Fetal Proteins (Fetoprotein)IBA 01/2018 - 09/2004
3	Calcineurin InhibitorsIBA 01/2017 - 01/2010
2	Carbapenems (Carbapenem Antibiotics)IBA 04/2024 - 12/2022
2	DNA (Deoxyribonucleic Acid)IBA 08/2021 - 07/2012
2	Transaminases (Aminotransferases)IBA 12/2020 - 02/2009
2	SirtuinsIBA 01/2017 - 10/2016
2	InterferonsIBA 04/2015 - 10/2012
2	Immunosuppressive Agents (Immunosuppressants)IBA 12/2013 - 01/2010
2	RNA (Ribonucleic Acid)IBA 06/2013 - 03/2013
2	SodiumIBA 11/2012 - 01/2009
2	AntibodiesIBA 08/2010 - 07/2009
1	SteroidsIBA 05/2024
1	SolutionsIBA 03/2024
1	Tacrolimus (Prograf)FDA LinkGeneric 03/2024
1	erythromycin propionate-N-acetylcysteinateIBA 12/2023
1	GlycogenIBA 06/2023
1	Reticulin (Reticular Fiber)IBA 03/2023
1	Coloring Agents (Dyes)IBA 03/2023

Therapy/Procedure

77	Liver Transplantation 04/2024 - 06/2003
44	Hepatectomy 04/2024 - 05/2003
31	Therapeutics 05/2024 - 06/2009
22	Transplantation 01/2023 - 09/2003
7	Radiofrequency Ablation 01/2022 - 11/2012
7	Contraindications 11/2021 - 10/2002
6	Drug Therapy (Chemotherapy) 08/2021 - 10/2011
5	Length of Stay 02/2024 - 12/2009
5	Ligation 02/2021 - 01/2012
4	Adjuvant Chemotherapy 01/2018 - 10/2011
3	Warm Ischemia 11/2021 - 01/2021
3	Blood Transfusion (Blood Transfusions) 12/2020 - 04/2008
2	Splenectomy 01/2021 - 05/2002
2	Pancreatectomy 04/2017 - 04/2009
2	Radiotherapy 01/2017 - 10/2016
2	Operative Surgical Procedures 05/2016 - 11/2013
2	Thrombectomy 07/2015 - 02/2011
2	Perioperative Care 06/2011 - 12/2009
2	Lymph Node Excision (Lymph Node Dissection) 08/2010 - 02/2004
2	Colectomy 01/2008 - 09/2003
1	Immunotherapy 05/2024
1	Colonic Pouches (S Pouch) 11/2023
1	Cannula 01/2023